login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ALPHA TAU MEDICAL LTD (DRTS) Stock News
USA
- NASDAQ:DRTS -
IL0011839383
-
Common Stock
3.75
USD
-0.14 (-3.6%)
Last: 10/17/2025, 8:07:12 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
DRTS Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
2 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
2 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau to Participate in Five September Investor Conferences
2 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
5 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau to Present at Jefferies Global Healthcare Conference
5 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau to Participate in May Investor Conferences
8 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau to Participate in March Investor Conferences
a year ago - By: BusinessInsider
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q2 2024
5 months ago - By: Stocktwits
Alpha Tau Stock Rallies To 3-Month High On Smaller-Than-Feared Q1 Loss: Retail Sentiment Stays Bearish
5 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
5 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
6 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
6 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
ORMP
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
a year ago - By: InvestorPlace
DRTS Stock Earnings: Alpha Tau Medical Beats EPS for Q2 2024
7 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
7 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
7 months ago - By: ACCESS Newswire
- Mentions:
GIFT
VOXR
FEMY
ZCAR
...
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
7 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
8 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
8 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
9 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
9 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
9 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
9 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
10 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
10 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
10 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor
10 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor
10 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference
11 months ago - By: Alpha Tau Medical Ltd.
Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau Treats First Patient with Recurrent Lung Cancer
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau Treats First Patient with Recurrent Lung Cancer
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor
a year ago - By: Alpha Tau Medical Ltd.
Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Please enable JavaScript to continue using this application.